Clinical trials are studying different chemotherapy drugs for childhood medulloblastoma. Treatment by type Treatment for childhood medulloblastoma depends on the type and stage of the disease and your child's age and overall health. Your child may receive treatment that is considered standard based on its effectiveness in a number of patients in past studies, or you may choose to have your child take part in a clinical trial. Not all patients are cured with standard therapy and some standard treatments may have more side effects than are desired. For these reasons, clinical trials are designed to test new treatments and to find better ways to treat cancer patients.
Clinical trials are ongoing in most parts of the country for childhood medulloblastoma.
After surgery, your child's treatment depends on the risk of the cancer coming back and the child's age. After surgery, your child will probably receive radiation therapy. Clinical trials are evaluating the role of reduced-dose radiation therapy plus chemotherapy. After surgery, your child will probably receive radiation therapy and chemotherapy. Clinical trials are evaluating whether chemotherapy can be given to children under the age of 3 to delay or reduce radiation therapy.